Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - Loss AllowanceNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Assets: 2011-2024

Historic Assets for RedHill Biopharma (RDHL) over the last 14 years, with Dec 2024 value amounting to $18.0 million.

  • RedHill Biopharma's Assets fell 16.57% to $18.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $18.4 million, marking a year-over-year decrease of 16.57%. This contributed to the annual value of $18.0 million for FY2024, which is 21.71% down from last year.
  • As of FY2024, RedHill Biopharma's Assets stood at $18.0 million, which was down 21.71% from $23.0 million recorded in FY2023.
  • In the past 5 years, RedHill Biopharma's Assets registered a high of $181.2 million during FY2021, and its lowest value of $18.0 million during FY2024.
  • Over the past 3 years, RedHill Biopharma's median Assets value was $23.0 million (recorded in 2023), while the average stood at $66.7 million.
  • Its Assets has fluctuated over the past 5 years, first soared by 143.24% in 2020, then plummeted by 85.49% in 2023.
  • Over the past 5 years, RedHill Biopharma's Assets (Yearly) stood at $180.2 million in 2020, then rose by 0.53% to $181.2 million in 2021, then dropped by 12.32% to $158.9 million in 2022, then slumped by 85.49% to $23.0 million in 2023, then fell by 21.71% to $18.0 million in 2024.